Oragenics Statistics
Total Valuation
Oragenics has a market cap or net worth of $3.52 million. The enterprise value is -$7.34 million.
Important Dates
The last earnings date was Friday, November 7, 2025, after market close.
| Earnings Date | Nov 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Oragenics has 4.17 million shares outstanding. The number of shares has increased by 1,588.05% in one year.
| Current Share Class | 4.17M |
| Shares Outstanding | 4.17M |
| Shares Change (YoY) | +1,588.05% |
| Shares Change (QoQ) | +113.29% |
| Owned by Insiders (%) | 1.21% |
| Owned by Institutions (%) | 3.64% |
| Float | 4.04M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.37 |
| P/TBV Ratio | 0.37 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.42, with a Debt / Equity ratio of 0.04.
| Current Ratio | 4.42 |
| Quick Ratio | 3.97 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -12.95 |
Financial Efficiency
Return on equity (ROE) is -168.95% and return on invested capital (ROIC) is -92.41%.
| Return on Equity (ROE) | -168.95% |
| Return on Assets (ROA) | -71.33% |
| Return on Invested Capital (ROIC) | -92.41% |
| Return on Capital Employed (ROCE) | -103.95% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.18M |
| Employee Count | 5 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -92.42% in the last 52 weeks. The beta is 0.90, so Oragenics's price volatility has been similar to the market average.
| Beta (5Y) | 0.90 |
| 52-Week Price Change | -92.42% |
| 50-Day Moving Average | 0.97 |
| 200-Day Moving Average | 2.52 |
| Relative Strength Index (RSI) | 45.85 |
| Average Volume (20 Days) | 80,531 |
Short Selling Information
The latest short interest is 139,273, so 3.34% of the outstanding shares have been sold short.
| Short Interest | 139,273 |
| Short Previous Month | 57,082 |
| Short % of Shares Out | 3.34% |
| Short % of Float | 3.45% |
| Short Ratio (days to cover) | 1.51 |
Income Statement
| Revenue | n/a |
| Gross Profit | -3.39M |
| Operating Income | -10.22M |
| Pretax Income | -10.90M |
| Net Income | -10.90M |
| EBITDA | n/a |
| EBIT | -10.22M |
| Earnings Per Share (EPS) | -$8.61 |
Full Income StatementBalance Sheet
The company has $11.40 million in cash and $394,836 in debt, with a net cash position of $11.01 million or $2.64 per share.
| Cash & Cash Equivalents | 11.40M |
| Total Debt | 394,836 |
| Net Cash | 11.01M |
| Net Cash Per Share | $2.64 |
| Equity (Book Value) | 9.83M |
| Book Value Per Share | 2.38 |
| Working Capital | 9.83M |
Full Balance SheetCash Flow
| Operating Cash Flow | -8.43M |
| Capital Expenditures | n/a |
| Free Cash Flow | -8.43M |
| FCF Per Share | -$2.02 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
